MR Antagonist and LSD1

MR Antagonist and LSD1
Conditions:   Hypertension;   Mineralocorticoid Excess
Interventions:   Drug: Eplerenone;   Drug: Amlodipine
Sponsor:   Brigham and Women’s Hospital
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 23, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments